ArticleEnvironmental health : a global access science source2026
Associations of arsenic exposure and folate in maternal leukocyte DNA methylation: a case-control study of mothers with spina-bifida affected children.
Article in Environmental health : a global access science source, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundIn Bangladesh, more than a quarter of drinking water tubewells are contaminated with arsenic above the national standard (50 µg/l), while nearly half exceed the World Health Organization guideline (10 µg/l). Among other negative health consequences, arsenic is a suspected environmental risk factor for neural tube defects (NTDs), including spina bifida. Maternal folate status protects against NTDs, though recent evidence suggests arsenic attenuates folate’s protective effects. Arsenic is methylated prior to excretion with methyl groups produced in one-carbon metabolism, for which folate is a cofactor. We thus hypothesized that DNA methylation (DNAme) may provide insight into the interactions between arsenic, maternal folate levels, and offspring spina bifida.
methodsHere we analyzed leukocyte DNAme using the Illumina MethylationEPIC v2.0 array in 374 women from Bangladesh, 246 with a previous spina-bifida affected birth and 128 controls. Chronic arsenic exposure was evaluated in maternal toenail; fasting plasma folate was measured at blood draw. Linear models evaluated DNAme associated with offspring spina bifida, arsenic, folate, and their interaction terms.
resultsMaternal DNAme was associated with spina bifida at 71 CpGs, arsenic at 6 CpGs, and folate at 33 CpGs (all FDR < 0.05). The spina bifida*arsenic and arsenic*folate interactions were associated with 11 and 28 CpGs, respectively, while spina bifida*folate returned no significant associations. We observed lower DNAme in mothers of spina bifida cases at significant loci, including in developmental genes such as HOXB3 and HOXB4. Arsenic’s influence on DNAme was more pronounced in individuals with low folate.
conclusionsOur work suggests that postnatal maternal leukocyte DNAme is associated with offspring spina bifida status and is modified by arsenic exposure but not plasma folate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.